Acyclovir CAS 59277-89-3 API Factory Antiviral High Quality
Manufacturer Supply with High Purity and Stable Quality
Chemical Name: Acyclovir
CAS: 59277-89-3
Antiviral used to treat HSV and VZV Infections
API High Quality, Commercial Production
| Chemical Name | Acyclovir |
| Synonyms | ACV; Acycloguanosine; 9-[(2-Hydroxyethoxy)methyl]guanine; Aciclovir |
| CAS Number | 59277-89-3 |
| CAT Number | RF-API83 |
| Stock Status | In Stock, Production Scale Up to Hundreds of Kilograms |
| Molecular Formula | C8H11N5O3 |
| Molecular Weight | 225.2 |
| Melting Point | 256.0~257.0℃ |
| Brand | Ruifu Chemical |
| Item | Specifications |
| Appearance | White or Almost White Crystalline Powder |
| Identification | Infrared Absorption; Retention Time (HPLC) |
| Related Substances | |
| Acetylguanine+Diacetylguanine | ≤0.60% |
| Other Max Single Impurity | ≤0.20% |
| Total Impurities | ≤1.0% |
| Water Content (by K.F) | ≤6.0% |
| Residual Solvents (GC) | ≤500ppm |
| Limit for Guanine (HPLC) | ≤0.70% |
| Assay | 98.0%~101.0% (C8H11N5O3 Calculated on the anhydrous basis) |
| Heavy Metals | ≤20ppm |
| Test Standard | Enterprise Standard |
| Usage | Antiviral used to treat HSV and VZV Infections |
Package: Bottle, Aluminum foil bag, Cardboard drum, 25kg/Drum, or according to customer's requirement.
Storage Condition: Store in sealed containers at cool and dry place; Protect from light, moisture and pest infestation.
Acyclovir (ACV, CAS 59277-89-3), also known as Acycloguanosine, is an antiviral medication. It is primarily used for the treatment of herpes simplex infections, chickenpox, and shingles. Other uses include prevention of cytomegalovirus infections following transplant and severe complications of Epstein-Barr virus infection. It can be taken by mouth, applied as a cream, or injected. Acyclovir is used to treat HSV and VZV infections. Acyclovir is a synthetic purine analog derived from guanine. It exerts its effects on the herpes simplex virus (HSV) and varicella-zoster virus by interfering with DNA synthesis through phosphorylation by viral thymidine kinase and subsequent inhibition of viral DNA polymerase, thereby inhibiting viral replication. Acyclovir was patented in 1974, and approved for medical use in 1981. It is on the World Health Organization's List of Essential Medicines. It is available as a generic medication and is marketed under many brand names worldwide.
